Digital Pharmacist
AUGUST 21, 2023
As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. The most effective preventive measure against the flu is getting an annual flu vaccine. According to the CDC, in the 2023-2024 season, the U.S.
Digital Pharmacist
SEPTEMBER 20, 2023
The Medicare Open Enrollment period for 2024 is quickly approaching – this is a critical time for both your patients and your pharmacy. Below is a breakdown of what you need to be aware of when assisting patients with 2024 open enrollments, as well as a few tips on how your pharmacy can prepare for this busy time at the pharmacy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
JANUARY 19, 2024
As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that will shape the future of this rapidly changing industry.
Hospital Pharmacy Europe
JUNE 23, 2023
The UK should introduce routine vaccination for respiratory syncytial virus (RSV) to protect babies and older adults, the Joint Committee on Vaccination and Immunisation (JCVI) has recommended. This article was originally published by our sister title Pulse.
STAT
FEBRUARY 1, 2024
On 2024 guidance, Merck said it expects sales in the range of $62.7-$64.2 In 2024, as in 2023, the industry’s fate seems inextricable from interest rates. If you’ve made it to the end of this article, you might be interested in joining this secret list for an upcoming biotech newsletter.
European Pharmaceutical Review
JANUARY 29, 2024
During 2023, there were five revisions to the European Medicines Agency ’s (EMA’s) Questions and Answers (Q&As) for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products. These changes are summarised in Table 1.
European Pharmaceutical Review
MAY 26, 2023
According to the MHRA, the recognition routes mark the start of a new international recognition framework for medicines that will be in place by the first quarter of 2024. Read the article on Boehringer Ingelheim’s ILAP designation here. This is a rare tumoural cancer which has not seen new first-line treatment in over forty years.
Expert insights. Personalized for you.
98 
Let's personalize your content